Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Equity Ratio (2016 - 2026)

Usana Health Sciences has reported Equity Ratio over the past 16 years, most recently at 0.74 for Q2 2026.

  • Quarterly Equity Ratio rose 3.66% to 0.74 in Q2 2026 from the year-ago period, while the trailing twelve-month figure was 0.74 through Apr 2026, up 3.66% year-over-year, with the annual reading at 0.72 for FY2026, 0.9% up from the prior year.
  • Equity Ratio was 0.74 for Q2 2026 at Usana Health Sciences, up from 0.72 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.81 in Q2 2024 and troughed at 0.68 in Q2 2022.
  • The 5-year median for Equity Ratio is 0.73 (2022), against an average of 0.74.
  • Year-over-year, Equity Ratio grew 10.48% in 2023 and then decreased 10.87% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.73 in 2022, then rose by 7.89% to 0.79 in 2023, then dropped by 9.49% to 0.71 in 2024, then rose by 2.19% to 0.73 in 2025, then rose by 1.21% to 0.74 in 2026.
  • Per Business Quant, the three most recent readings for USNA's Equity Ratio are 0.74 (Q2 2026), 0.72 (Q1 2026), and 0.73 (Q3 2025).